In this study, the cutoff for biochemical adherence/nonadherence was a serum tamoxifen level of 60 ng/mL.
Early initiation of breast cancer screening with MRI may reduce breast cancer mortality by more than half.
Even among women with breast implants, just over half have heard of BIA-ALCL.
Continuously-modified 4R care sequencing templates incorporating patient navigator learning was described as a means of facilitating breast cancer care delivery.
Research findings from ESMO confirm that patients with cancer can improve their symptoms of CRF if they “avoid inactivity”; in addition, greater use of supportive care can also help.
Survivorship care plan consultations led by breast care nurses reported significantly higher percentage of patients having issues, and were more likely to include referrals for follow-up appointments.
Significant reductions in uninsured patients, in advanced-stage disease, especially in African-Americans.
The FDA has approved Phesgo™ (pertuzumab, trastuzumab, hyaluronidase-zzxf; Genentech), in combination with chemotherapy, for the treatment of early and metastatic HER2-positive breast cancer.
Researchers evaluated the prevalence, level, and impact on QOL of patient-reported urinary incontinence at baseline and after 3 months of systemic therapy.
The incidence of breast cancer for postmenopausal women included in the NIH-AARP study was evaluated with respect to level of outdoor light at night.